Analgesics in Italy in 2026 is registering notably weaker momentum than previous years, as underlying demand continues to contract and price increases become the main lever for nominal expansion. The combination of a flat population, subdued real GDP growth and higher inflation constrain spending power, while shifting consumer priorities favour preventive health solutions and supplements over reactive pain relief, diverting expenditure away from analgesics. The environment remains challenging for new entrants or disruptive players, as the landscape remains concentrated, with the leading manufacturers consolidating share through established brands, deep consumer trust and broad portfolios, leaving little room for challengers. Success increasingly depends on differentiation, with brands needing to invest in age-friendly formulations, wellness-focused products and omnichannel strategies that leverage the growth of online pharmacy platforms, while also strengthening engagement with healthcare professionals to maintain loyalty as generics and digital channels intensify competition. For most players, the environment is less attractive for high-volume growth, but offers opportunities in value retention and loyalty among older, less price-sensitive consumers through innovation and targeted communication.
Delivery:
Files are delivered directly into your account soon after payment is received and any tax is certification is verified (where applicable).
This report comes in PDF with additional info in Excel included.
Overview:
Understand the latest market trends and future growth opportunities for the Analgesics industry in Italy with research from Euromonitor International's team of in-country analysts – experts by industry and geographic specialisation.
Key trends are clearly and succinctly summarised alongside the most current research data available. Understand and assess competitive threats and plan corporate strategy with our qualitative analysis, insight and confident growth projections.
If you're in the Analgesics industry in Italy, our research will help you to make informed, intelligent decisions; to recognise and profit from opportunity, or to offer resilience amidst market uncertainty.
The Analgesics in Italy report includes:
- Analysis of key supply-side and demand trends
- Detailed segmentation of international and local products
- Historic volume and value sizes, company and brand market shares
- Five year forecasts of market trends and market growth
- Robust and transparent research methodology, conducted in-country
This report answers:
- What is the market size of Analgesics in Italy?
- Which are the leading brands in Analgesics in Italy?
- How are products distributed in Analgesics in Italy?
- How has the regulatory and operating environment for Analgesics changed in Italy?
- How are considerations such as stress, self-medication and shifting consumer lifestyles shaping demand for Analgesics
- How significant are wider health concerns and consumer awareness in determining sales?
- Where is future growth expected to be most dynamic?
Key Data Insights
Key Industry Trends
Preventive health shift and structural constraints mute Italy’s analgesics growth
Systemic analgesics lead by value as topical formats capture stronger growth
Online expansion and service-led differentiation define retail shift
Chart 1 Value Sales 2021-2031
Chart 2 Value Sales by Category 2026
Brands to prioritise product differentiation to retain value as generics grow
Systemic options to dominate as tailored solutions drive loyalty
Chart 1 Forecast Value Sales 2021-2031
Chart 2 Forecast Value Sales by Category 2026-2031
Tachipirina and Voltaren reinforce brand leadership
Chart 1 Company Shares 2026
Chart 2 Brand Shares 2026
Pharmacies maintain shopper loyalty as digital platforms expand
Chart 1 Retail Channels 2021-2026
Bayer and Reckitt target shifting demand with new formats
Chart 1 Real GDP Growth 2021-2031
Chart 2 Inflation 2021-2031
Chart 1 Population 2021-2031
Chart 2 Population by Generation 2026
Chart 3 Consumer Expenditure 2021-2031
Country Reports Disclaimer
The following categories and subcategories are included:
Analgesics
-
-
- Adult Acetaminophen
- Adult Aspirin
- Adult Combination Products - Analgesics
- Adult Diclofenac
- Adult Dipyrone
- Adult Ibuprofen
- Adult Ketoprofen
- Adult Naproxen
- Adult OTC Triptans
-
- Paediatric Acetaminophen
- Paediatric Aspirin
- Paediatric Combination Products - Analgesics
- Paediatric Dipyrone
- Paediatric Ibuprofen
- Paediatric Naproxen
-
- Acetaminophen
- Aspirin
- Combination Products - Analgesics
- Diclofenac
- Dipyrone
- Ibuprofen
- Ketoprofen
- Naproxen
- OTC Triptans
-
- Topical Analgesics/Anaesthetic
Analgesics
Analgesics cover systemic and topical pain relievers. Products which include a pain-relief ingredient in addition to another core function are excluded (e.g. a sore throat remedy which includes paracetamol is excluded from the analgesics and instead is included in pharyngeal remedies).
See all of our definitionsWhy buy this report?
- Gain competitive intelligence about market leaders
- Track key industry trends, opportunities and threats
- Inform your marketing, brand, strategy and market development, sales and supply functions
This report originates from Passport, our Analgesics research and analysis database.
NEW REPORT GUARANTEE
If you purchase a report that is updated in the next 60 days, we will send you the new edition and data extraction Free!